Literature DB >> 25774500

Severe myopathy in mice lacking the MEF2/SRF-dependent gene leiomodin-3.

Bercin K Cenik, Ankit Garg, John R McAnally, John M Shelton, James A Richardson, Rhonda Bassel-Duby, Eric N Olson, Ning Liu.   

Abstract

Maintenance of skeletal muscle structure and function requires a precise stoichiometry of sarcomeric proteins for proper assembly of the contractile apparatus. Absence of components of the sarcomeric thin filaments causes nemaline myopathy, a lethal congenital muscle disorder associated with aberrant myofiber structure and contractility. Previously, we reported that deficiency of the kelch-like family member 40 (KLHL40) in mice results in nemaline myopathy and destabilization of leiomodin-3 (LMOD3). LMOD3 belongs to a family of tropomodulin-related proteins that promote actin nucleation. Here, we show that deficiency of LMOD3 in mice causes nemaline myopathy. In skeletal muscle, transcription of Lmod3 was controlled by the transcription factors SRF and MEF2. Myocardin-related transcription factors (MRTFs), which function as SRF coactivators, serve as sensors of actin polymerization and are sequestered in the cytoplasm by actin monomers. Conversely, conditions that favor actin polymerization de-repress MRTFs and activate SRF-dependent genes. We demonstrated that the actin nucleator LMOD3, together with its stabilizing partner KLHL40, enhances MRTF-SRF activity. In turn, SRF cooperated with MEF2 to sustain the expression of LMOD3 and other components of the contractile apparatus, thereby establishing a regulatory circuit to maintain skeletal muscle function. These findings provide insight into the molecular basis of the sarcomere assembly and muscle dysfunction associated with nemaline myopathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25774500      PMCID: PMC4396495          DOI: 10.1172/JCI80115

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Authors:  Ning Liu; Svetlana Bezprozvannaya; John M Shelton; Madlyn I Frisard; Matthew W Hulver; Ryan P McMillan; Yaru Wu; Kevin A Voelker; Robert W Grange; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

2.  Muscle-specific signaling mechanism that links actin dynamics to serum response factor.

Authors:  Koichiro Kuwahara; Tomasa Barrientos; G C Teg Pipes; Shijie Li; Eric N Olson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Filament assembly by Spire: key residues and concerted actin binding.

Authors:  Amy S Rasson; Justin S Bois; Duy Stephen L Pham; Haneul Yoo; Margot E Quinlan
Journal:  J Mol Biol       Date:  2014-09-16       Impact factor: 5.469

4.  Leiomodin 3 and tropomodulin 4 have overlapping functions during skeletal myofibrillogenesis.

Authors:  Chinedu U Nworu; Robert Kraft; Daniel C Schnurr; Carol C Gregorio; Paul A Krieg
Journal:  J Cell Sci       Date:  2014-11-27       Impact factor: 5.285

5.  Clinical course correlates poorly with muscle pathology in nemaline myopathy.

Authors:  M M Ryan; B Ilkovski; C D Strickland; C Schnell; D Sanoudou; C Midgett; R Houston; D Muirhead; X Dennett; L K Shield; U De Girolami; S T Iannaccone; N G Laing; K N North; A H Beggs
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

Review 6.  New players in actin polymerization--WH2-domain-containing actin nucleators.

Authors:  Britta Qualmann; Michael M Kessels
Journal:  Trends Cell Biol       Date:  2009-05-04       Impact factor: 20.808

7.  Leiomodin is an actin filament nucleator in muscle cells.

Authors:  David Chereau; Malgorzata Boczkowska; Aneta Skwarek-Maruszewska; Ikuko Fujiwara; David B Hayes; Grzegorz Rebowski; Pekka Lappalainen; Thomas D Pollard; Roberto Dominguez
Journal:  Science       Date:  2008-04-11       Impact factor: 47.728

8.  Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.

Authors:  Hye Joo Kim; Hyung Joo Lee; Hyojin Kim; Seung Woo Cho; Jin-Soo Kim
Journal:  Genome Res       Date:  2009-05-21       Impact factor: 9.043

9.  Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL.

Authors:  Maria K Vartiainen; Sebastian Guettler; Banafshe Larijani; Richard Treisman
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

10.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.

Authors:  Tomas Cermak; Erin L Doyle; Michelle Christian; Li Wang; Yong Zhang; Clarice Schmidt; Joshua A Baller; Nikunj V Somia; Adam J Bogdanove; Daniel F Voytas
Journal:  Nucleic Acids Res       Date:  2011-04-14       Impact factor: 16.971

View more
  29 in total

1.  The cardiomyopathy-associated K15N mutation in tropomyosin alters actin filament pointed end dynamics.

Authors:  Mert Colpan; Thu Ly; Samantha Grover; Dmitri Tolkatchev; Alla S Kostyukova
Journal:  Arch Biochem Biophys       Date:  2017-07-18       Impact factor: 4.013

Review 2.  Tropomodulins and Leiomodins: Actin Pointed End Caps and Nucleators in Muscles.

Authors:  Velia M Fowler; Roberto Dominguez
Journal:  Biophys J       Date:  2017-05-09       Impact factor: 4.033

3.  Knockout of Lmod2 results in shorter thin filaments followed by dilated cardiomyopathy and juvenile lethality.

Authors:  Christopher T Pappas; Rachel M Mayfield; Christine Henderson; Nima Jamilpour; Cathleen Cover; Zachary Hernandez; Kirk R Hutchinson; Miensheng Chu; Ki-Hwan Nam; Jose M Valdez; Pak Kin Wong; Henk L Granzier; Carol C Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-20       Impact factor: 11.205

4.  Characterizing interaction forces between actin and proteins of the tropomodulin family reveals the presence of the N-terminal actin-binding site in leiomodin.

Authors:  Baran Arslan; Mert Colpan; Kevin T Gray; Nehal I Abu-Lail; Alla S Kostyukova
Journal:  Arch Biochem Biophys       Date:  2017-12-06       Impact factor: 4.013

5.  Neonatal fractures as a presenting feature of LMOD3-associated congenital myopathy.

Authors:  Megan Abbott; Mahim Jain; Rachel Pferdehirt; Yuqing Chen; Alyssa Tran; Mehmet B Duz; Mehmet Seven; Richard A Gibbs; Donna Muzny; Brendan Lee; Ronit Marom; Lindsay C Burrage
Journal:  Am J Med Genet A       Date:  2017-08-16       Impact factor: 2.802

6.  Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.

Authors:  Danny Halim; Michael P Wilson; Daniel Oliver; Erwin Brosens; Joke B G M Verheij; Yu Han; Vivek Nanda; Qing Lyu; Michael Doukas; Hans Stoop; Rutger W W Brouwer; Wilfred F J van IJcken; Orazio J Slivano; Alan J Burns; Christine K Christie; Karen L de Mesy Bentley; Alice S Brooks; Dick Tibboel; Suowen Xu; Zheng Gen Jin; Tono Djuwantono; Wei Yan; Maria M Alves; Robert M W Hofstra; Joseph M Miano
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

7.  Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage.

Authors:  Yan Cao; Liang Wang; Junhong Zhao; Hongbing Zhang; Ying Tian; Houcheng Liang; Qiang Ma
Journal:  J Mol Neurosci       Date:  2016-01-23       Impact factor: 3.444

8.  HSPB7 is indispensable for heart development by modulating actin filament assembly.

Authors:  Tongbin Wu; Yongxin Mu; Julius Bogomolovas; Xi Fang; Jennifer Veevers; Roberta B Nowak; Christopher T Pappas; Carol C Gregorio; Sylvia M Evans; Velia M Fowler; Ju Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

9.  Tropomodulin 1 directly controls thin filament length in both wild-type and tropomodulin 4-deficient skeletal muscle.

Authors:  David S Gokhin; Julien Ochala; Andrea A Domenighetti; Velia M Fowler
Journal:  Development       Date:  2015-11-19       Impact factor: 6.868

10.  Myocardin-related transcription factors are required for skeletal muscle development.

Authors:  Bercin K Cenik; Ning Liu; Beibei Chen; Svetlana Bezprozvannaya; Eric N Olson; Rhonda Bassel-Duby
Journal:  Development       Date:  2016-07-06       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.